Trials / Not Yet Recruiting
Not Yet RecruitingNCT07158970
Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)
Effect of Home Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Wolfson Medical Center · Other Government
- Sex
- Female
- Age
- 18 Years – 51 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the impact of incorporating home-ultrasound (home-US) devices into telemedicine care for patients with gestational diabetes mellitus (GDM). The study will compare satisfaction, clinical outcomes, and healthcare costs between standard high-risk pregnancy care and care augmented by home-US.
Detailed description
Gestational diabetes mellitus (GDM) requires frequent follow-up to monitor maternal and fetal well-being. While telemedicine improves access and patient satisfaction, it lacks a fetal assessment component. This single-center randomized controlled trial evaluates the integration of home ultrasound (home-US) into telemedicine care for women with GDM. Participants will be randomized to standard care or an intervention group receiving alternating in-person and telemedicine visits with physician-guided home-US using the Pulsenmore device. The primary outcome is patient satisfaction measured by the Diabetes Treatment Satisfaction Questionnaire (DTSQ) at term. Secondary outcomes include glycemic control, maternal and neonatal outcomes, healthcare utilization, visit duration, and follow-up costs. The study will enroll 90 women, aged 18-51, with singleton pregnancies and GDM. The study is conducted at the Edith Wolfson Medical Center in Israel over a one-year period. The home-US device is approved for obstetric use and will be used under real-time physician supervision.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Use of the Pulsenmore home ultrasound device for fetal assessment, guided remotely by a physician. | Standard care |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2027-08-31
- Completion
- 2027-11-01
- First posted
- 2025-09-08
- Last updated
- 2025-09-18
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT07158970. Inclusion in this directory is not an endorsement.